Comparison of Corneal and Aqueous Humor Penetration of Moxifloxacin, Gatifloxacin and Levofloxacin during Keratoplasty

[1]  K. Sugioka,et al.  Intraocular penetration of sequentially instilled topical moxifloxacin, gatifloxacin, and levofloxacin , 2009, Clinical ophthalmology.

[2]  J. Hyon,et al.  Kill rates of preserved and preservative‐free topical 8‐methoxy fluoroquinolones against various strains of Staphylococcus , 2009, Journal of cataract and refractive surgery.

[3]  C. Baudouin.  Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma , 2008, Acta ophthalmologica.

[4]  S. Scoper.  Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy , 2008, Advances in therapy.

[5]  Terry Kim,et al.  Ocular Penetration and Pharmacokinetics of Topical Gatifloxacin 0.3% and Moxifloxacin 0.5% Ophthalmic Solutions After Keratoplasty , 2008, Cornea.

[6]  H. Sasaki,et al.  Calculation of AQCmax: comparison of five ophthalmic fluoroquinolone solutions*. , 2008, Current medical research and opinion.

[7]  S. Robertson,et al.  A novel in vivo rabbit model that mimics human dosing to determine the distribution of antibiotics in ocular tissues. , 2007, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[8]  Lindsay Brown.  Resistance to ocular antibiotics: an overview , 2007, Clinical & experimental optometry.

[9]  J. McCulley,et al.  Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. , 2006, Ophthalmology.

[10]  K. Ishikawa,et al.  Corneal penetration of simultaneously applied topical levofloxacin, norfloxacin and lomefloxacin in human eyes. , 2005, Acta ophthalmologica Scandinavica.

[11]  D. Welty,et al.  Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. , 2006, Survey of ophthalmology.

[12]  J. Dick,et al.  Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. , 2005, Ophthalmology.

[13]  S. Masket,et al.  Absorption of Topical Moxifloxacin Ophthalmic Solution Into Human Aqueous Humor , 2005, Cornea.

[14]  H. Flynn,et al.  Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. , 2005, American journal of ophthalmology.

[15]  T. O'brien,et al.  Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery , 2005, Current medical research and opinion.

[16]  D. Hwang.  Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. , 2004, Survey of ophthalmology.

[17]  M. Yamada,et al.  Aqueous humor levels of topically applied levofloxacin, norfloxacin, and lomefloxacin in the same human eyes , 2003 .

[18]  E. Romanowski,et al.  Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. , 2003, American journal of ophthalmology.

[19]  P. McDonnell,et al.  Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model. , 2003, American journal of ophthalmology.

[20]  K. Drlica,et al.  In Vitro Pharmacodynamic Evaluation of the Mutant Selection Window Hypothesis Using Four Fluoroquinolones against Staphylococcus aureus , 2003, Antimicrobial Agents and Chemotherapy.

[21]  E. Romanowski,et al.  Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. , 2002, American journal of ophthalmology.

[22]  Xilin Zhao,et al.  Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window. , 2002, The Journal of infectious diseases.

[23]  T. Liesegang.  Use of antimicrobials to prevent postoperative infection in patients with cataracts. , 2001, Current opinion in ophthalmology.

[24]  W. Hamilton,et al.  Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. , 2000, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[25]  G. Alexandrakis,et al.  Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. , 2000, Ophthalmology.

[26]  J. Baum,et al.  Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review , 1999 .

[27]  F. Price,et al.  Corneal tissue levels of topically applied ofloxacin , 1997, Journal of cataract and refractive surgery.

[28]  R. Snyder,et al.  Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin. , 1997, Archives of ophthalmology.

[29]  J. Diamond,et al.  Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration. , 1995, The British journal of ophthalmology.

[30]  T. Mauger,et al.  Havener's Ocular Pharmacology , 1994 .